The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 8, 2023 | Arkowitz David | Director | Tender(U) | 8K | $7.12 | $60K |
| Mar 8, 2023 | Arkowitz David | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 8, 2023 | Arkowitz David | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 8, 2023 | Benz Edward JR | Director | Disposed to issuer(D) | 4K | $7.12 | $31K |
| Mar 8, 2023 | Benz Edward JR | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 8, 2023 | Benz Edward JR | Director | Disposed to issuer(D) | 4K | — | — |
| Mar 8, 2023 | Benz Edward JR | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 8, 2023 | Bermingham Nessan | Director | Tender(U) | 98K | $7.12 | $695K |
| Mar 8, 2023 | Bermingham Nessan | Director | Disposed to issuer(D) | 6K | $7.12 | $45K |
| Mar 8, 2023 | Bermingham Nessan | Director | Disposed to issuer(D) | 34K | — | — |
| Mar 8, 2023 | Bermingham Nessan | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 8, 2023 | Bermingham Nessan | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 8, 2023 | Race Geoffrey | Director | Tender(U) | 4K | $7.12 | $28K |
| Mar 8, 2023 | Race Geoffrey | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 8, 2023 | Race Geoffrey | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 8, 2023 | Brewis Neil | CHIEF SCIENTIFIC OFFICER | Tender(U) | 105K | $7.12 | $748K |
| Mar 8, 2023 | Brewis Neil | CHIEF SCIENTIFIC OFFICER | Disposed to issuer(D) | 9K | $7.12 | $67K |
| Mar 8, 2023 | Brewis Neil | CHIEF SCIENTIFIC OFFICER | Disposed to issuer(D) | 23K | — | — |
| Mar 8, 2023 | Brewis Neil | CHIEF SCIENTIFIC OFFICER | Disposed to issuer(D) | 74K | — | — |
| Mar 8, 2023 | Brewis Neil | CHIEF SCIENTIFIC OFFICER | Disposed to issuer(D) | 132K | — | — |
| Mar 8, 2023 | Brady Todd C | Director | Tender(U) | 15K | $7.12 | $107K |
| Mar 8, 2023 | Brady Todd C | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 8, 2023 | Brady Todd C | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 8, 2023 | Deptula-Hicks Darlene M | See Remarks | Disposed to issuer(D) | 26K | $7.12 | $182K |
| Mar 8, 2023 | Deptula-Hicks Darlene M | See Remarks | Tender(U) | 31K | $7.12 | $220K |
| Mar 8, 2023 | Deptula-Hicks Darlene M | See Remarks | Disposed to issuer(D) | 28K | — | — |
| Mar 8, 2023 | Deptula-Hicks Darlene M | See Remarks | Disposed to issuer(D) | 26K | — | — |
| Mar 8, 2023 | Deptula-Hicks Darlene M | See Remarks | Disposed to issuer(D) | 25K | — | — |
| Mar 8, 2023 | Deptula-Hicks Darlene M | See Remarks | Disposed to issuer(D) | 60K | — | — |
| Mar 8, 2023 | Klein Pamela M. | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 8, 2023 | Klein Pamela M. | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 8, 2023 | Forster Eliot | PRESIDENT AND CEO, Director | Disposed to issuer(D) | 74K | $7.12 | $527K |
| Mar 8, 2023 | Forster Eliot | PRESIDENT AND CEO, Director | Tender(U) | 348K | $7.12 | $2.5M |
| Mar 8, 2023 | Forster Eliot | PRESIDENT AND CEO, Director | Disposed to issuer(D) | 128K | — | — |
| Mar 8, 2023 | Forster Eliot | PRESIDENT AND CEO, Director | Disposed to issuer(D) | 165K | — | — |
| Mar 8, 2023 | Forster Eliot | PRESIDENT AND CEO, Director | Disposed to issuer(D) | 127K | — | — |
| Mar 8, 2023 | Kayitalire Louis | CHIEF MEDICAL OFFICER | Tender(U) | 29K | $7.12 | $208K |
| Mar 8, 2023 | Kayitalire Louis | CHIEF MEDICAL OFFICER | Disposed to issuer(D) | 25K | $7.12 | $178K |
| Mar 8, 2023 | Kayitalire Louis | CHIEF MEDICAL OFFICER | Disposed to issuer(D) | 13K | — | — |
| Mar 8, 2023 | Kayitalire Louis | CHIEF MEDICAL OFFICER | Disposed to issuer(D) | 54K | — | — |
| Mar 8, 2023 | Kayitalire Louis | CHIEF MEDICAL OFFICER | Disposed to issuer(D) | 27K | — | — |
| Mar 8, 2023 | Kayitalire Louis | CHIEF MEDICAL OFFICER | Disposed to issuer(D) | 36K | — | — |
| Jul 29, 2022 | Forster Eliot | President and CEO, Director | Option exercise(M) | 33K | — | $0 |
| Jul 29, 2022 | Forster Eliot | President and CEO, Director | Option exercise(M) | 228K | — | $0 |
| Jul 29, 2022 | Forster Eliot | President and CEO, Director | Option exercise(M) | 261K | $0.11 | $29K |
| Jul 29, 2022 | Brewis Neil | Chief Scientific Officer | Option exercise(M) | 70K | — | $0 |
| Jul 29, 2022 | Brewis Neil | Chief Scientific Officer | Option exercise(M) | 6K | — | $0 |
| Jul 29, 2022 | Brewis Neil | Chief Scientific Officer | Option exercise(M) | 77K | $0.11 | $8K |
| Jul 29, 2022 | Race Geoffrey | Director | Option exercise(M) | 4K | $0.11 | $433 |
| Jul 29, 2022 | Race Geoffrey | Director | Option exercise(M) | 4K | — | $0 |
| Jun 17, 2022 | Brady Todd C | Director | Grant(A) | 20K | — | $0 |
| Jun 17, 2022 | Race Geoffrey | Director | Grant(A) | 20K | — | $0 |
| Jun 17, 2022 | Benz Edward JR | Director | Grant(A) | 20K | — | $0 |
| Jun 17, 2022 | Klein Pamela M. | Director | Grant(A) | 20K | — | $0 |
| Jun 17, 2022 | Bermingham Nessan | Director | Grant(A) | 20K | — | $0 |
| Jun 17, 2022 | Arkowitz David | Director | Grant(A) | 20K | — | $0 |
| Mar 31, 2022 | Forster Eliot | President and CEO, Director | Grant(A) | 127K | — | $0 |
| Mar 31, 2022 | Deptula-Hicks Darlene M | Treasurer and CFO | Grant(A) | 25K | — | $0 |
| Mar 31, 2022 | Kayitalire Louis | Chief Medical Officer | Grant(A) | 36K | — | $0 |
| Mar 31, 2022 | Brewis Neil | Chief Scientific Officer | Grant(A) | 132K | — | $0 |
| Jan 9, 2022 | Kayitalire Louis | Chief Medical Officer | Grant(A) | 54K | — | $0 |
| Jan 9, 2022 | Deptula-Hicks Darlene M | Treasurer and CFO | Grant(A) | 60K | — | $0 |
| Jan 9, 2022 | Brewis Neil | Chief Scientific Officer | Grant(A) | 74K | — | $0 |
| Jan 9, 2022 | Forster Eliot | President and CEO, Director | Grant(A) | 165K | — | $0 |
| Nov 2, 2021 | Kayitalire Louis | Chief Medical Officer | Sell(S) | 39 | $6.81 | $266 |
| Nov 2, 2021 | Kayitalire Louis | Chief Medical Officer | Sell(S) | 25 | $6.85 | $171 |
| Oct 4, 2021 | Kayitalire Louis | Chief Medical Officer | Sell(S) | 64 | $7.23 | $463 |
| Jul 2, 2021 | Kayitalire Louis | Chief Medical Officer | Sell(S) | 1K | $8.43 | $9K |
| Jun 4, 2021 | Krol Patrick Johan Hendrik | Director | Grant(A) | 20K | — | $0 |
| Jun 4, 2021 | Klein Pamela M. | Director | Grant(A) | 20K | — | $0 |
| Jun 4, 2021 | Brady Todd C | Director | Grant(A) | 20K | — | $0 |
| Jun 4, 2021 | Bermingham Nessan | Director | Grant(A) | 20K | — | $0 |
| Jun 4, 2021 | Race Geoffrey | Director | Grant(A) | 20K | — | $0 |
| Jun 4, 2021 | Benz Edward JR | Director | Grant(A) | 20K | — | $0 |
| Jun 4, 2021 | Arkowitz David | Director | Grant(A) | 20K | — | $0 |
| Nov 20, 2020 | Bermingham Nessan | Director | Grant(A) | 17K | — | $0 |
| Nov 20, 2020 | Deptula-Hicks Darlene M | Treasurer and CFO | Grant(A) | 26K | — | $0 |
| Nov 20, 2020 | Kayitalire Louis | Chief Medical Officer | Grant(A) | 26K | — | $0 |
| Nov 20, 2020 | Arkowitz David | Director | Other(J) | 8K | — | — |
| Nov 20, 2020 | Arkowitz David | Director | Other(J) | 4K | — | — |
| Nov 20, 2020 | Arkowitz David | Director | Other(J) | 8K | — | — |
| Nov 20, 2020 | Arkowitz David | Director | Other(J) | 6K | — | — |
| Nov 20, 2020 | Arkowitz David | Director | Other(J) | 10K | — | — |
| Nov 20, 2020 | Arkowitz David | Director | Other(J) | 6K | — | — |
| Nov 20, 2020 | Arkowitz David | Director | Other(J) | 6K | — | — |
| Nov 20, 2020 | Brady Todd C | Director | Other(J) | 8K | — | — |
| Nov 20, 2020 | Brady Todd C | Director | Other(J) | 8K | — | — |
| Nov 20, 2020 | Brady Todd C | Director | Other(J) | 6K | — | — |
| Nov 20, 2020 | Brady Todd C | Director | Other(J) | 6K | — | — |
| Nov 20, 2020 | Brady Todd C | Director | Other(J) | 11K | — | — |
| Nov 20, 2020 | Brady Todd C | Director | Other(J) | 11K | — | — |
| Nov 20, 2020 | Klein Pamela M. | Director | Other(J) | 8K | — | — |
| Nov 20, 2020 | Klein Pamela M. | Director | Other(J) | 15K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).